Basit öğe kaydını göster

dc.contributor.authorTuzlali, Sitki
dc.contributor.authorKeskin, Serkan
dc.contributor.authorBengisu, Ergin
dc.contributor.authorAydiner, Adnan
dc.date.accessioned2021-03-06T10:13:38Z
dc.date.available2021-03-06T10:13:38Z
dc.identifier.citationKeskin S., Bengisu E., Tuzlali S., Aydiner A., "Complete Response in a Patient with Granulosa Cell Tumor Treated with a Combination of Leuprolide and Tamoxifen", ONKOLOGIE, cilt.35, ss.451-453, 2012
dc.identifier.issn0378-584X
dc.identifier.othervv_1032021
dc.identifier.otherav_e95ed2eb-4fb6-4e56-8c5d-0cf8c7ff12a5
dc.identifier.urihttp://hdl.handle.net/20.500.12627/153331
dc.identifier.urihttps://doi.org/10.1159/000341078
dc.description.abstractBackground: Adult granulosa cell tumors (GCTs) are frequently hormonally active. Thus, hormonal agents have been evaluated for the treatment of advanced-stage or recurrent disease. Case Report: A 39-year-old patient presented with recurrent GCT. The patient received multiple treatment modalities, including surgery and 2 different chemotherapy regimens (cisplatin- and taxane-based). Abdominal computed tomography following these treatments showed local recurrence with multiple implants. The patient's inhibin B level increased to 187 pg/ml at this time. The patient was treated with leuprolide 11.25 mg every 3 months and tamoxifen 20 mg twice daily. The patient's inhibin B level began to decrease after 1 month and returned to normal after 4 months. The patient has been maintained on this treatment for 2 years and has tolerated the drugs well. Conclusion: The combination of leuprolide and tamoxifen had limited side effects in the presented patient and might be a viable treatment option for women with advanced-stage or recurrent adult ovarian GCTs.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleComplete Response in a Patient with Granulosa Cell Tumor Treated with a Combination of Leuprolide and Tamoxifen
dc.typeMakale
dc.relation.journalONKOLOGIE
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume35
dc.identifier.startpage451
dc.identifier.endpage453
dc.contributor.firstauthorID202866


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster